抗血栓薬の世界市場 2023-2027

抗血栓薬市場は2022-2027年に231億9,994万米ドル、予測期間中のCAGRは8.42％で成長すると予測されます。

当レポートでは、抗血栓薬市場の全体的な分析、市場規模・予測、動向、市場促進要因・促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。凝固障害の有病率の増加、新規経口抗凝固薬のイントロダクション、強力な研究開発パイプラインの構築などが市場を牽引しています。

本調査では、抗凝固解毒剤の登場が今後数年間の抗血栓薬市場成長を牽引する主要因の1つであると特定しています。また、市場の焦点である企業の戦略的提携や買収、市場の焦点である新興国市場の開拓は、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2022
• 市場の見通し 2022-2027

第4章 市場規模実績

• 抗血栓薬の世界市場 2017-2021
• 投与経路セグメント分析 2017-2021
• 流通チャネルセグメント分析 2017-2021
• 地域別セグメント分析 2017-2021
• 国別セグメント分析 2017-2021

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：投与経路別

• 市場セグメント
• 比較：投与経路別
• オーラル：市場規模と予測 2022-2027
• 注射可能：市場規模と予測 2022-2027
• 市場機会：投与経路別

第7章 市場セグメンテーション：流通チャネル別

• 市場セグメント
• 比較：流通チャネル別
• 病院薬局：市場規模と予測 2022-2027
• 小売薬局：市場規模と予測 2022-2027
• オンライン薬局：市場規模と予測 2022-2027
• 市場機会：流通チャネル別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2022-2027
• 欧州：市場規模と予測 2022-2027
• アジア：市場規模と予測 2022-2027
• 世界のその他の地域：市場規模と予測 2022-2027
• 米国：市場規模と予測 2022-2027
• ドイツ：市場規模と予測 2022-2027
• 英国：市場規模と予測 2022-2027
• 日本：市場規模と予測 2022-2027
• カナダ：市場規模と予測 2022-2027
• 地域情勢別市場機会

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Aspen Pharmacare Holdings Ltd
• AstraZeneca PLC
• Bayer AG
• Boehringer Ingelheim International GmbH
• Bristol Myers Squibb Co.
• Daiichi Sankyo Co. Ltd.
• Eli Lilly and Co.
• F. Hoffmann La Roche Ltd.
• Fresenius Kabi AG
• Hikma Pharmaceuticals Plc
• Novartis AG
• Otsuka Pharmaceutical Co. Ltd.
• Sanofi SA
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
• Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on global antithrombotic drugs market 2017 - 2021 ($ million)
• Exhibits19: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
• Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Route of Administration - Market share 2022-2027 (%)
• Exhibits31: Data Table on Route of Administration - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Route of Administration
• Exhibits33: Data Table on Comparison by Route of Administration
• Exhibits34: Chart on Oral - Market size and forecast 2022-2027 ($ million)
• Exhibits35: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
• Exhibits36: Chart on Oral - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Oral - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Injectable - Market size and forecast 2022-2027 ($ million)
• Exhibits39: Data Table on Injectable - Market size and forecast 2022-2027 ($ million)
• Exhibits40: Chart on Injectable - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Injectable - Year-over-year growth 2022-2027 (%)
• Exhibits42: Market opportunity by Route of Administration ($ million)
• Exhibits43: Data Table on Market opportunity by Route of Administration ($ million)
• Exhibits44: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibits45: Data Table on Distribution Channel - Market share 2022-2027 (%)
• Exhibits46: Chart on Comparison by Distribution Channel
• Exhibits47: Data Table on Comparison by Distribution Channel
• Exhibits48: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibits49: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibits50: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibits51: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibits52: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibits53: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibits54: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibits55: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibits56: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibits57: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibits58: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibits59: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibits60: Market opportunity by Distribution Channel ($ million)
• Exhibits61: Data Table on Market opportunity by Distribution Channel ($ million)
• Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits65: Chart on Geographic comparison
• Exhibits66: Data Table on Geographic comparison
• Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits89: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits91: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits93: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibits94: Data Table on UK - Year-over-year growth 2022-2027 (%)
• Exhibits95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibits96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibits97: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibits98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
• Exhibits99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits101: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits103: Market opportunity By Geographical Landscape ($ million)
• Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits105: Impact of drivers and challenges in 2022 and 2027
• Exhibits106: Overview on Criticality of inputs and Factors of differentiation
• Exhibits107: Overview on factors of disruption
• Exhibits108: Impact of key risks on business
• Exhibits109: Vendors covered
• Exhibits110: Matrix on vendor position and classification
• Exhibits111: Aspen Pharmacare Holdings Ltd - Overview
• Exhibits112: Aspen Pharmacare Holdings Ltd - Business segments
• Exhibits113: Aspen Pharmacare Holdings Ltd - Key offerings
• Exhibits114: Aspen Pharmacare Holdings Ltd - Segment focus
• Exhibits115: AstraZeneca PLC - Overview
• Exhibits116: AstraZeneca PLC - Product / Service
• Exhibits117: AstraZeneca PLC - Key news
• Exhibits118: AstraZeneca PLC - Key offerings
• Exhibits119: Bayer AG - Overview
• Exhibits120: Bayer AG - Business segments
• Exhibits121: Bayer AG - Key news
• Exhibits122: Bayer AG - Key offerings
• Exhibits123: Bayer AG - Segment focus
• Exhibits124: Boehringer Ingelheim International GmbH - Overview
• Exhibits125: Boehringer Ingelheim International GmbH - Business segments
• Exhibits126: Boehringer Ingelheim International GmbH - Key news
• Exhibits127: Boehringer Ingelheim International GmbH - Key offerings
• Exhibits128: Boehringer Ingelheim International GmbH - Segment focus
• Exhibits129: Bristol Myers Squibb Co. - Overview
• Exhibits130: Bristol Myers Squibb Co. - Product / Service
• Exhibits131: Bristol Myers Squibb Co. - Key news
• Exhibits132: Bristol Myers Squibb Co. - Key offerings
• Exhibits133: Daiichi Sankyo Co. Ltd. - Overview
• Exhibits134: Daiichi Sankyo Co. Ltd. - Product / Service
• Exhibits135: Daiichi Sankyo Co. Ltd. - Key news
• Exhibits136: Daiichi Sankyo Co. Ltd. - Key offerings
• Exhibits137: Eli Lilly and Co. - Overview
• Exhibits138: Eli Lilly and Co. - Product / Service
• Exhibits139: Eli Lilly and Co. - Key news
• Exhibits140: Eli Lilly and Co. - Key offerings
• Exhibits141: F. Hoffmann La Roche Ltd. - Overview
• Exhibits142: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits143: F. Hoffmann La Roche Ltd. - Key news
• Exhibits144: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits145: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits146: Fresenius Kabi AG - Overview
• Exhibits147: Fresenius Kabi AG - Business segments
• Exhibits148: Fresenius Kabi AG - Key news
• Exhibits149: Fresenius Kabi AG - Key offerings
• Exhibits150: Fresenius Kabi AG - Segment focus
• Exhibits151: Hikma Pharmaceuticals Plc - Overview
• Exhibits152: Hikma Pharmaceuticals Plc - Business segments
• Exhibits153: Hikma Pharmaceuticals Plc - Key offerings
• Exhibits154: Hikma Pharmaceuticals Plc - Segment focus
• Exhibits155: Novartis AG - Overview
• Exhibits156: Novartis AG - Business segments
• Exhibits157: Novartis AG - Key offerings
• Exhibits158: Novartis AG - Segment focus
• Exhibits159: Otsuka Pharmaceutical Co. Ltd. - Overview
• Exhibits160: Otsuka Pharmaceutical Co. Ltd. - Product / Service
• Exhibits161: Otsuka Pharmaceutical Co. Ltd. - Key offerings
• Exhibits162: Sanofi SA - Overview
• Exhibits163: Sanofi SA - Business segments
• Exhibits164: Sanofi SA - Key news
• Exhibits165: Sanofi SA - Key offerings
• Exhibits166: Sanofi SA - Segment focus
• Exhibits167: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits168: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits169: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits170: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits171: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits172: Viatris Inc. - Overview
• Exhibits173: Viatris Inc. - Business segments
• Exhibits174: Viatris Inc. - Key news
• Exhibits175: Viatris Inc. - Key offerings
• Exhibits176: Viatris Inc. - Segment focus
• Exhibits177: Inclusions checklist
• Exhibits178: Exclusions checklist
• Exhibits179: Currency conversion rates for US$
• Exhibits180: Research methodology
• Exhibits181: Validation techniques employed for market sizing
• Exhibits182: Information sources
• Exhibits183: List of abbreviations

The antithrombotic drugs market is forecasted to grow by USD 23,199.94 mn during 2022-2027, accelerating at a CAGR of 8.42% during the forecast period. The report on the antithrombotic drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing prevalence of coagulation disorders, the introduction of novel oral anticoagulants, and a strong r and d pipeline in building.

Technavio's antithrombotic drugs market is segmented as below:

By Route of Administration

• Oral
• Injectable

By Distribution Channel

• Hospital pharmacy
• Retail pharmacy
• Online pharmacy

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advent of anticoagulant antidotes as one of the prime reasons driving the antithrombotic drugs market growth during the next few years. Also, strategic partnerships and acquisitions of companies in market focus and growing new developments in market focus will lead to sizable demand in the market.

The report on the antithrombotic drugs market covers the following areas:

• Antithrombotic drugs market sizing
• Antithrombotic drugs market forecast
• Antithrombotic drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antithrombotic drugs market vendors that include AbbVie Inc., Aspen Pharmacare Holdings Ltd, AstraZeneca PLC, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Otsuka Pharmaceutical Co. Ltd., Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Fresenius Kabi AG. Also, the antithrombotic drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global antithrombotic drugs market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on global antithrombotic drugs market 2017 - 2021 ($ million)
• 4.2 Route of Administration Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
• 4.3 Distribution Channel Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Route of Administration

• 6.1 Market segments
• Exhibit 30: Chart on Route of Administration - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Route of Administration - Market share 2022-2027 (%)
• 6.2 Comparison by Route of Administration
• Exhibit 32: Chart on Comparison by Route of Administration
• Exhibit 33: Data Table on Comparison by Route of Administration
• 6.3 Oral - Market size and forecast 2022-2027
• Exhibit 34: Chart on Oral - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Oral - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Oral - Year-over-year growth 2022-2027 (%)
• 6.4 Injectable - Market size and forecast 2022-2027
• Exhibit 38: Chart on Injectable - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Injectable - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Injectable - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Injectable - Year-over-year growth 2022-2027 (%)
• 6.5 Market opportunity by Route of Administration
• Exhibit 42: Market opportunity by Route of Administration ($ million)
• Exhibit 43: Data Table on Market opportunity by Route of Administration ($ million)

7 Market Segmentation by Distribution Channel

• 7.1 Market segments
• Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
• 7.2 Comparison by Distribution Channel
• Exhibit 46: Chart on Comparison by Distribution Channel
• Exhibit 47: Data Table on Comparison by Distribution Channel
• 7.3 Hospital pharmacy - Market size and forecast 2022-2027
• Exhibit 48: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibit 50: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibit 51: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
• 7.4 Retail pharmacy - Market size and forecast 2022-2027
• Exhibit 52: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
• 7.5 Online pharmacy - Market size and forecast 2022-2027
• Exhibit 56: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibit 58: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
• 7.6 Market opportunity by Distribution Channel
• Exhibit 60: Market opportunity by Distribution Channel ($ million)
• Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 65: Chart on Geographic comparison
• Exhibit 66: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 Germany - Market size and forecast 2022-2027
• Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.9 UK - Market size and forecast 2022-2027
• Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 9.10 Japan - Market size and forecast 2022-2027
• Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
• 9.11 Canada - Market size and forecast 2022-2027
• Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 103: Market opportunity By Geographical Landscape ($ million)
• Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 105: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 107: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 108: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 109: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 110: Matrix on vendor position and classification
• 12.3 Aspen Pharmacare Holdings Ltd
• Exhibit 111: Aspen Pharmacare Holdings Ltd - Overview
• Exhibit 112: Aspen Pharmacare Holdings Ltd - Business segments
• Exhibit 113: Aspen Pharmacare Holdings Ltd - Key offerings
• Exhibit 114: Aspen Pharmacare Holdings Ltd - Segment focus
• 12.4 AstraZeneca PLC
• Exhibit 115: AstraZeneca PLC - Overview
• Exhibit 116: AstraZeneca PLC - Product / Service
• Exhibit 117: AstraZeneca PLC - Key news
• Exhibit 118: AstraZeneca PLC - Key offerings
• 12.5 Bayer AG
• Exhibit 119: Bayer AG - Overview
• Exhibit 120: Bayer AG - Business segments
• Exhibit 121: Bayer AG - Key news
• Exhibit 122: Bayer AG - Key offerings
• Exhibit 123: Bayer AG - Segment focus
• 12.6 Boehringer Ingelheim International GmbH
• Exhibit 124: Boehringer Ingelheim International GmbH - Overview
• Exhibit 125: Boehringer Ingelheim International GmbH - Business segments
• Exhibit 126: Boehringer Ingelheim International GmbH - Key news
• Exhibit 127: Boehringer Ingelheim International GmbH - Key offerings
• Exhibit 128: Boehringer Ingelheim International GmbH - Segment focus
• 12.7 Bristol Myers Squibb Co.
• Exhibit 129: Bristol Myers Squibb Co. - Overview
• Exhibit 130: Bristol Myers Squibb Co. - Product / Service
• Exhibit 131: Bristol Myers Squibb Co. - Key news
• Exhibit 132: Bristol Myers Squibb Co. - Key offerings
• 12.8 Daiichi Sankyo Co. Ltd.
• Exhibit 133: Daiichi Sankyo Co. Ltd. - Overview
• Exhibit 134: Daiichi Sankyo Co. Ltd. - Product / Service
• Exhibit 135: Daiichi Sankyo Co. Ltd. - Key news
• Exhibit 136: Daiichi Sankyo Co. Ltd. - Key offerings
• 12.9 Eli Lilly and Co.
• Exhibit 137: Eli Lilly and Co. - Overview
• Exhibit 138: Eli Lilly and Co. - Product / Service
• Exhibit 139: Eli Lilly and Co. - Key news
• Exhibit 140: Eli Lilly and Co. - Key offerings
• 12.10 F. Hoffmann La Roche Ltd.
• Exhibit 141: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 142: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 143: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 144: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 145: F. Hoffmann La Roche Ltd. - Segment focus
• 12.11 Fresenius Kabi AG
• Exhibit 146: Fresenius Kabi AG - Overview
• Exhibit 147: Fresenius Kabi AG - Business segments
• Exhibit 148: Fresenius Kabi AG - Key news
• Exhibit 149: Fresenius Kabi AG - Key offerings
• Exhibit 150: Fresenius Kabi AG - Segment focus
• 12.12 Hikma Pharmaceuticals Plc
• Exhibit 151: Hikma Pharmaceuticals Plc - Overview
• Exhibit 152: Hikma Pharmaceuticals Plc - Business segments
• Exhibit 153: Hikma Pharmaceuticals Plc - Key offerings
• Exhibit 154: Hikma Pharmaceuticals Plc - Segment focus
• 12.13 Novartis AG
• Exhibit 155: Novartis AG - Overview
• Exhibit 156: Novartis AG - Business segments
• Exhibit 157: Novartis AG - Key offerings
• Exhibit 158: Novartis AG - Segment focus
• 12.14 Otsuka Pharmaceutical Co. Ltd.
• Exhibit 159: Otsuka Pharmaceutical Co. Ltd. - Overview
• Exhibit 160: Otsuka Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 161: Otsuka Pharmaceutical Co. Ltd. - Key offerings
• 12.15 Sanofi SA
• Exhibit 162: Sanofi SA - Overview
• Exhibit 163: Sanofi SA - Business segments
• Exhibit 164: Sanofi SA - Key news
• Exhibit 165: Sanofi SA - Key offerings
• Exhibit 166: Sanofi SA - Segment focus
• 12.16 Teva Pharmaceutical Industries Ltd.
• Exhibit 167: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 168: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 169: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 170: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 171: Teva Pharmaceutical Industries Ltd. - Segment focus
• 12.17 Viatris Inc.
• Exhibit 172: Viatris Inc. - Overview
• Exhibit 173: Viatris Inc. - Business segments
• Exhibit 174: Viatris Inc. - Key news
• Exhibit 175: Viatris Inc. - Key offerings
• Exhibit 176: Viatris Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 177: Inclusions checklist
• Exhibit 178: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 179: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 180: Research methodology
• Exhibit 181: Validation techniques employed for market sizing
• Exhibit 182: Information sources
• 13.5 List of abbreviations
• Exhibit 183: List of abbreviations